Damian deGoa

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC.

Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breas Medical AB is a Swedish company that manufactures home respiratory ventilators and sleep apnea products. The company is based in Mölnlycke, Sweden. Breas Medical was acquired by Human Design Medical LLC, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from General Electric Co. on February 04, 2014.

PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia.

Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. The company was founded in 1887 and is headquartered in Allegan, MI.